4.7 Article

Clinical characteristics and outcomes of influenza and other influenza-like illnesses in Mexico City

Journal

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
Volume 17, Issue 7, Pages E510-E517

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.ijid.2013.01.006

Keywords

Respiratory viral pathogens; Epidemiology; Hospital burden of disease; Influenza; Respiratory syncytial virus; Rhinovirus; Coronavirus

Funding

  1. Mexico Ministry of Health
  2. U.S. National Institute of Allergy and Infectious Diseases
  3. CONACYT through FONSEC SSA/IMSS/ISSSTE [71260, 127088]
  4. Westat, Inc. [HHSN2722009000031]
  5. National Cancer Institute, National Institutes of Health, 318 [HHSN261200800001E]

Ask authors/readers for more resources

Background: Influenza-like illnesses (ILI) are estimated to cause millions of deaths annually. Despite this disease burden, the etiologic causes of ILI are poorly described for many geographical regions. Methods: Beginning in April 2010, we conducted an observational cohort study at five hospitals in Mexico City, enrolling subjects who met the criteria for ILI. Evaluations were conducted at enrollment and on day 28, with the collection of clinical data and a nasopharyngeal swab (or nasal aspirate in children). Swabs were tested by multiplex PCR for 15 viral pathogens and real-time PCR for influenza. Results: During the first year, 1065 subjects were enrolled in this study, 55% of whom were hospitalized; 24% of all subjects were children. One or more pathogens were detected by PCR in 64% of subjects, most commonly rhinovirus (25% of all isolates) and influenza (24% of isolates). Six percent of subjects died, and of those, 54% had no pathogen identified. Rhinovirus was the most common pathogen among those who died, although it did not have the highest case fatality rate. Conclusions: Multiple respiratory viruses beyond influenza are associated with significant morbidity and mortality among adults and children in Mexico City. Detection of these agents could be useful for the adjustment of antibiotic treatment in severe cases. (C) 2013 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available